User profiles for Cyrille Féray

Cyrille Féray

Hôpital Paul Brousse
Verified email at aphp.fr
Cited by 11516

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C

…, C Castelnau, AC Cardoso, T Asselah, C Féray… - Gastroenterology, 2008 - Elsevier
Background & Aims: It is unclear whether hepatitis C virus (HCV) is eradicated in patients
with chronic hepatitis C who achieved a sustained virologic response (SVR). Methods: In this …

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C

C Féray, L Caccamo, GJM Alexander, B Ducot… - Gastroenterology, 1999 - Elsevier
Background & Aims: Liver transplantation for hepatitis C virus (HCV)-related liver disease is
characterized by frequent graft infection by HCV. The prognosis and risk factors for morbidity …

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

…, C Vanlemmens, R Moirand, C Féray… - The Lancet …, 2022 - thelancet.com
Background Early liver transplantation for severe alcohol-related hepatitis is an emerging
treatment option. We aimed to assess the risk of alcohol relapse 2 years after early liver …

[PDF][PDF] Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

JC Duclos‐Vallée, C Féray, M Sebagh, E Teicher… - …, 2008 - Wiley Online Library
Liver transplantation in patients coinfected with human immunodeficiency virus (HIV) and
hepatitis C virus (HCV) is a recent indication. In a single center, we have compared the survival …

Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease

…, F Saliba, P Ichai, H Farahmand, M Gigou, C Féray… - Journal of …, 1999 - Elsevier
Background/Aims: After liver transplantionfor autoimmune hepatitis, the long-term results and
the incidence of recurrence of primary disease are unknown. Methods: In this retrospective …

[PDF][PDF] Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes

…, F Penin, R Kara, Y Richard, E Dussaix, C Féray - …, 2004 - Wiley Online Library
Differences in the composition of the hepatitis C virus (HCV) quasispecies between plasma
and blood mononuclear cells (BMC) strongly suggest that BMCs support viral replication. We …

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

…, C Moreno, A Oussalah, C Féray… - The Lancet …, 2022 - thelancet.com
Background Hepatocellular carcinoma is a frequent consequence of alcohol-related liver
disease, with variable incidence among heavy drinkers. We did a genome-wide association …

[PDF][PDF] All liver recipients benefit from the protocol 10‐year liver biopsies

M Sebagh, K Rifai, C Féray, F Yilmaz, B Falissard… - …, 2003 - Wiley Online Library
The value of late protocol biopsies after liver transplantation remains to be evaluated to
highlight the therapeutic policies. The study population was composed of patients who survived …

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

…, J Dupuis, B Terrier, C Feray… - American journal of …, 2015 - Wiley Online Library
Hepatitis C virus (HCV) infection increases the risk of B‐cell non‐Hodgkin lymphomas (B‐NHL).
Antiviral treatment (AT) can induce hematological responses in patients with marginal …

Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells

…, M Gigou, E Dussaix, D Samuel, C Féray - Journal of …, 2005 - Am Soc Microbiol
Differences in hepatitis C virus (HCV) variants of the highly conserved 5′ untranslated
region (UTR) have been observed between plasma and peripheral blood mononuclear cells (…